-
Avorelin
- names:
Avorelin
- CAS号:
140703-49-7
MDL Number: - MF(分子式): C65H85N17O12 MW(分子量): 1296.502
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | (S)-1-(((R)-2-((S)-2-((S)-2-((S)-2-((S)-3-(1H-imidazol-4-yl)-2-((S)-5-oxopyrrolidine-2-carboxamido)propanamido)-3-(1H-indol-3-yl)propanamido)-3-hydroxypropanamido)-3-(4-hydroxyphenyl)propanamido)-3-(2-methyl-1H-indol-3-yl)propanoyl)-L-leucyl-L-arginyl)-N-ethylpyrrolidine-2-carboxamide |
| 英文别名 | Avorelin; EP-23904; MF-6001; EP23904; MF6001; EP 23904; MF 6001. Meterelin; 2-Me-D-Trp(6),desgly(10)-LHRH ethylamide. |
| CAS号 | 140703-49-7 |
| Inchi | InChI=1S/C65H85N17O12/c1-5-69-63(93)54-17-11-25-82(54)64(94)47(16-10-24-70-65(66)67)75-57(87)48(26-35(2)3)76-61(91)52(30-43-36(4)73-45-15-9-7-13-42(43)45)80-58(88)49(27-37-18-20-40(84)21-19-37)77-62(92)53(33-83)81-59(89)50(28-38-31-71-44-14-8-6-12-41(38)44)78-60(90)51(29-39-32-68-34-72-39)79-56(86)46-22-23-55(85)74-46/h6-9,12-15,18-21,31-32,34-35,46-54,71,73,83-84H,5,10-11,16-17,22-30,33H2,1-4H3,(H,68,72)(H,69,93)(H,74,85)(H,75,87)(H,76,91)(H,77,92)(H,78,90)(H,79,86)(H,80,88)(H,81,89)(H4,66,67,70)/t46-,47-,48-,49-,50-,51-,52+,53-,54-/m0/s1 |
| InchiKey | HJNZCKLMRAOTMA-BRBGIFQRSA-N |
| 分子式 Formula | C65H85N17O12 |
| 分子量 Molecular Weight | 1296.502 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | Avorelin(CAS:140703-49-7):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | Avorelin, also known as EP-23904, MF-6001, Meterelin, is a luteinizing hormone releasing hormone (LH-RH) agonist potentially for the treatment of prostate. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Kaisary AV, Bowsher WG, Gillatt DA, Anderson JB, Malone PR, Imbimbo BP.Pharmacodynamics of a long acting depot preparation of avorelin in patients withprostate cancer. Avorelin Study Group. J Urol. 1999 Dec;162(6):2019-23. PubMedPMID: 10569560. |
| [2]Brown GR, Dixson AF. Investigation of the role of postnatal testosterone inthe expression of sex differences in behavior in infant rhesus macaques (Macacamulatta). Horm Behav. 1999 Apr;35(2):186-94. PubMed PMID: 10202126. |
| [3] Brown GR, Nevison CM, Fraser HM, Dixson AF. Manipulation of postnataltestosterone levels affects phallic and clitoral development in infant rhesusmonkeys. Int J Androl. 1999 Apr;22(2):119-28. PubMed PMID: 10194644. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


